Table TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 [see all tables in this series...]

Part (iv) Percentage distribution of route of administration amongst new clients with hypnotics and sedatives as primary drug

Country		Inject	Smoke/inhale	Eat/drink	Sniff	Others	Base (known status)	Status unknown
Czech Republic		12.5	0.0	87.5	0.0	0.0	8	0
Denmark		0.0	0.0	100.0	0.0	0.0	10	0
Germany		2.1	2.1	92.1	0.5	3.1	420	314
Ireland		0.0	0.0	100.0	0.0	0.0	34	0
Greece		0.0	7.7	92.3	0.0	0.0	13	0
Spain	(1)	0.0	0.8	95.0	3.7	0.5	378	19
France		0.0	3.1	92.2	0.0	4.7	64	4
Italy		10.7	11.9	64.4	13.0	0.0	177	0
Latvia		0.0	7.1	92.9	0.0	0.0	28	3
Lithuania		0.0	0.0	100.0	0.0	0.0	2	0
Hungary		5.3	0.0	93.9	0.0	0.8	131	0
Malta		0.0	0.0	100.0	0.0	0.0	1	0
Netherlands	(2)	0.0	0.0	97.5	0.8	1.7	120	5
Austria		0.0	0.0	100.0	0.0	0.0	28	0
Slovakia		0.0	0.0	100.0	0.0	0.0	6	0
Finland		5.6	0.0	94.4	0.0	0.0	18	1
Sweden		0.0	0.0	97.3	0.9	1.8	112	2
United Kingdom	(3)	0.5	1.0	96.2	0.5	1.7	1093	52
Total		1.6	1.9	93.2	1.8	1.6	2643	400

Notes:

 Only countries where there are clients reported with hypnotics and sedatives as primary drug are shown. 

 (1) Data refer to 2005. 

 (2) Data refer to outpatient treatment centres and low-threshold agencies. 

 (3) Data refer to collection period between 1.4.2005 and 31.3.2006. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)